drugset / Trial / NCT02429271

A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study

NCT02429271

Phase 3 Completed 336 enrolled Hellenic Cardiovascular Research Society
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective randomized study, which investigates the coronary microvascular function as assessed by coronary angiography after administration of ticagrelor compared with clopidogrel in patients with myocardial infarction and ST segment elevation after thrombolysis.

Timeline

Start
2015-08
Primary completion
2019-02
Completion
2019-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg
Comparator Ticagrelor Small molecule 180 mg